Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-02 Sale |
2023-03-03 4:31 pm |
Kymera Therapeutics Inc. | KYMR | Caughey Elaine Chief Business Officer |
714 | $31 | $22,132 | 82,324 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 4:30 pm |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
1,298 | $31 | $40,233 | 187,209 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 4:30 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
1,370 | $31 | $42,465 | 247,068 (Direct) |
View |
| 2023-01-11 Purchase |
2023-01-13 5:08 pm |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes |
41,007 | $30.51 | $1,251,191 | 2,218,295 (Indirect Direct) |
View |
| 2023-01-11 Sale |
2023-01-13 4:53 pm |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
126,474 | $30.22 | $3,821,739 | 890,148 (Indirect) |
View |
| 2023-01-11 Sale |
2023-01-13 4:50 pm |
Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
126,474 | $30.22 | $3,821,739 | 5,858,262 (Indirect Direct) |
View |
| 2022-12-14 Sale |
2022-12-16 5:05 pm |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
382,244 | $31.36 | $11,985,954 | 917,811 (Indirect) |
View |
| 2022-12-14 Sale |
2022-12-16 5:03 pm |
Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
382,244 | $31.36 | $11,985,954 | 5,984,736 (Indirect Direct) |
View |
| 2022-11-02 Sale |
2022-11-04 4:31 pm |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
220,016 | $30.01 | $6,602,952 | 1,001,417 (Indirect) |
View |
| 2022-11-02 Sale |
2022-11-04 4:30 pm |
Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
220,016 | $30.01 | $6,602,952 | 6,366,980 (Indirect Direct) |
View |
| 2022-10-28 Sale |
2022-11-01 7:36 pm |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
288,702 | $30.26 | $8,735,143 | 1,049,540 (Indirect) |
View |
| 2022-10-28 Sale |
2022-11-01 7:34 pm |
Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
288,702 | $30.26 | $8,735,143 | 6,586,996 (Indirect Direct) |
View |
| 2022-08-22 Purchase |
2022-08-23 5:35 pm |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes |
545,525 | $26 | $14,183,650 | 329,944 (Indirect Direct) |
View |
| 2022-05-26 Purchase |
2022-05-31 7:50 pm |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes |
289,426 | $14.34 | $4,150,321 | 290,827 (Indirect Direct) |
View |
| 2022-05-20 Purchase |
2022-05-24 8:09 pm |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes |
10,100 | $14 | $141,394 | 276,962 (Indirect Direct) |
View |
| 2022-05-05 Purchase |
2022-05-09 7:20 pm |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes |
250,000 | $19.46 | $4,865,365 | 276,925 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-22 Option Award |
2023-05-22 7:35 pm |
N/A 2023-05-22 |
Kymera Therapeutics Inc. | KYMR | Chadwick Jeremy G Chief Operating Officer |
233,333 | $0 | 233,333 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:31 pm |
N/A 2033-02-28 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
450,000 | $0 | 450,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:31 pm |
N/A 2033-02-28 |
Kymera Therapeutics Inc. | KYMR | Caughey Elaine Chief Business Officer |
73,895 | $0 | 82,324 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:30 pm |
N/A 2033-02-28 |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
131,250 | $0 | 187,209 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:30 pm |
N/A 2033-02-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
166,250 | $0 | 247,068 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:35 pm |
N/A 2033-01-02 |
Kymera Therapeutics Inc. | KYMR | Chiniara Ellen Chief Legal Officer |
262,500 | $0 | 262,500 (Direct) |
View |
| 2022-12-08 Exercise |
2022-12-08 6:11 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
10,000 | $2.08 | 592,425 (Direct) |
View |
| 2022-12-08 Exercise |
2022-12-08 6:11 pm |
N/A 2029-11-13 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
10,000 | $0 | 592,425 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-03 7:22 pm |
N/A 2032-11-02 |
Kymera Therapeutics Inc. | KYMR | Sandor Victor Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2022-10-21 Exercise |
2022-10-24 08:00 am |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 221,178 (Direct) |
View |
| 2022-10-21 Exercise |
2022-10-24 08:00 am |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 221,178 (Direct) |
View |
| 2022-10-17 Exercise |
2022-10-17 8:12 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 221,178 (Direct) |
View |
| 2022-10-17 Exercise |
2022-10-17 8:12 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 221,178 (Direct) |
View |
| 2022-10-17 Exercise |
2022-10-17 8:09 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
59,732 | $2.08 | 1,122,903 (Direct) |
View |
| 2022-10-17 Exercise |
2022-10-17 8:09 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
59,732 | $0 | 1,122,903 (Direct) |
View |
| 2022-07-06 Option Award |
2022-07-08 4:10 pm |
N/A 2032-07-05 |
Kymera Therapeutics Inc. | KYMR | Morgan Leigh Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2022-06-29 Option Award |
2022-07-01 4:05 pm |
N/A 2032-06-28 |
Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 7:20 pm |
N/A 2032-06-14 |
Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes |
12,000 | $0 | 4,126,451 (Indirect) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:06 pm |
N/A 2032-06-14 |
Kymera Therapeutics Inc. | KYMR | Hrustanovic Gorjan Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:06 pm |
N/A 2032-06-14 |
Kymera Therapeutics Inc. | KYMR | Nicholson Donald William Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:06 pm |
N/A 2032-06-14 |
Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:05 pm |
N/A 2032-06-14 |
Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:05 pm |
N/A 2032-06-14 |
Kymera Therapeutics Inc. | KYMR | Booth Bruce Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:05 pm |
N/A 2032-06-14 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:05 pm |
N/A 2032-06-14 |
Kymera Therapeutics Inc. | KYMR | Horobin Joanna Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-05-04 Exercise |
2022-05-04 09:02 am |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
10,208 | $1.31 | 196,076 (Direct) |
View |
| 2022-05-04 Exercise |
2022-05-04 09:02 am |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
9,792 | $2.08 | 196,076 (Direct) |
View |
| 2022-05-04 Exercise |
2022-05-04 09:02 am |
N/A 2028-10-31 |
Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer |
20,000 | $0 | 196,076 (Direct) |
View |
| 2022-05-03 Exercise |
2022-05-03 7:27 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
20,000 | $2.08 | 548,623 (Direct) |
View |
| 2022-05-03 Exercise |
2022-05-03 7:27 pm |
N/A 2029-05-22 |
Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer |
20,000 | $0 | 548,623 (Direct) |
View |